BlackRock Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-600
Closed -$39K 3612
2014
Q4
$39K Buy
+600
New +$37.8K ﹤0.01% 3334

Other funds holding ABBV

BlackRock Advisors's ABBV Position: Q4 2016 in Review

BlackRock Advisors increased its AbbVie (ABBV) stake by 2% in Q4 2016, buying an estimated $2.76M and bringing the position to 2,253,908 shares worth $141M. The position accounts for 0.14% of the portfolio, ranked #158.

BlackRock Advisors first reported a position in ABBV in Q2 2013 and has held it in 15 quarters since. The position peaked at $987M in Q2 2015. 1,691 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

  • BlackRock Advisors held 2,253,908 shares of AbbVie worth $141M as of Q4 2016.
  • BlackRock Advisors bought 45,191 AbbVie shares in Q4 2016, an estimated $2.76M.
  • AbbVie made up 0.14% of BlackRock Advisors's portfolio in Q4 2016, its #158 holding.
  • BlackRock Advisors first reported a position in AbbVie in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's AbbVie position peaked at $987M in Q2 2015.
  • 1,691 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.